{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:08:32Z","timestamp":1782821312443,"version":"3.54.5"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41380-026-03496-5","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T09:30:50Z","timestamp":1771320650000},"page":"3618-3636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protective mutations associated with APOE in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"31","author":[{"given":"Yuejia","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangrun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuchen","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-9977","authenticated-orcid":false,"given":"Qing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2204-427X","authenticated-orcid":false,"given":"Fuyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9672-3347","authenticated-orcid":false,"given":"Dayong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"3496_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40142-019-0156-2","volume":"7","author":"SJ Andrews","year":"2019","unstructured":"Andrews SJ, Fulton-Howard B, Goate A. Protective variants in Alzheimer\u2019s disease. Curr Genet Med Rep. 2019;7:1\u201312.","journal-title":"Curr Genet Med Rep"},{"key":"3496_CR2","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","volume":"368","author":"MD Hurd","year":"2013","unstructured":"Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of dementia in the United States. N Engl J Med. 2013;368:1326\u201334.","journal-title":"N Engl J Med"},{"key":"3496_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u201390.","journal-title":"Lancet"},{"key":"3496_CR4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/mp.2015.177","volume":"21","author":"JI V\u00e9lez","year":"2016","unstructured":"V\u00e9lez JI, Lopera F, Sepulveda-Falla D, Patel HR, Johar AS, Chuah A, et al. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer\u2019s disease. Mol Psychiatry. 2016;21:916\u201324.","journal-title":"Mol Psychiatry"},{"key":"3496_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-2725-z","volume":"17","author":"KL Ayers","year":"2016","unstructured":"Ayers KL, Mirshahi UL, Wardeh AH, Murray MF, Hao K, Glicksberg BS, et al. A loss of function variant in CASP7 protects against Alzheimer\u2019s disease in homozygous APOE \u03b54 allele carriers. BMC Genomics. 2016;17:445.","journal-title":"BMC Genomics"},{"key":"3496_CR6","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41593-023-01480-8","volume":"26","author":"MR Nelson","year":"2023","unstructured":"Nelson MR, Liu P, Agrawal A, Yip O, Blumenfeld J, Traglia M, et al. The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. Nat Neurosci. 2023;26:2104\u201321.","journal-title":"Nat Neurosci"},{"key":"3496_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/exnr.1996.6360","volume":"143","author":"DJ Stone","year":"1997","unstructured":"Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Hajian H, Finch CE. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp Neurol. 1997;143:313\u20138.","journal-title":"Exp Neurol"},{"key":"3496_CR8","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci. 2006;26:4985\u201394.","journal-title":"J Neurosci"},{"key":"3496_CR9","first-page":"128","volume":"21","author":"J Poirier","year":"1996","unstructured":"Poirier J. Apolipoprotein E in the brain and its role in Alzheimer\u2019s disease. J Psychiatry Neurosci. 1996;21:128\u201334.","journal-title":"J Psychiatry Neurosci"},{"key":"3496_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3940(95)11763-M","volume":"195","author":"T Uchihara","year":"1995","unstructured":"Uchihara T, Duyckaerts C, He Y, Kobayashi K, Seilhean D, Amouyel P, et al. ApoE immunoreactivity and microglial cells in Alzheimer\u2019s disease brain. Neurosci Lett. 1995;195:5\u20138.","journal-title":"Neurosci Lett"},{"key":"3496_CR11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41593-021-00851-3","volume":"24","author":"KA Zalocusky","year":"2021","unstructured":"Zalocusky KA, Najm R, Taubes AL, Hao Y, Yoon SY, Koutsodendris N, et al. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer\u2019s disease. Nat Neurosci. 2021;24:786\u201398.","journal-title":"Nat Neurosci"},{"key":"3496_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2741\/A290","volume":"3","author":"L Nilsson","year":"1998","unstructured":"Nilsson L, Rogers J, Potter H. The essential role of inflammation and induced gene expression in the pathogenic pathway of Alzheimer\u2019s disease. Front Biosci. 1998;3:436\u201346.","journal-title":"Front Biosci"},{"key":"3496_CR13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0197-4580(01)00308-6","volume":"22","author":"H Potter","year":"2001","unstructured":"Potter H, Wefes IM, Nilsson LN. The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation. Neurobiol Aging. 2001;22:923\u201330.","journal-title":"Neurobiol Aging"},{"key":"3496_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/1568007054038229","volume":"4","author":"AJ Rozemuller","year":"2005","unstructured":"Rozemuller AJ, van Gool WA, Eikelenboom P. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer\u2019s disease: therapeutic implications. Curr Drug Targets CNS Neurol Disord. 2005;4:223\u201333.","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"3496_CR15","volume":"2012","author":"H Potter","year":"2012","unstructured":"Potter H, Wisniewski T. Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade. Int J Alzheimers Dis. 2012;2012:489428.","journal-title":"Int J Alzheimers Dis"},{"key":"3496_CR16","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.neurobiolaging.2003.12.011","volume":"25","author":"LN Nilsson","year":"2004","unstructured":"Nilsson LN, Arendash GW, Leighty RE, Costa DA, Low MA, Garcia MF, et al. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiol Aging. 2004;25:1153\u201367.","journal-title":"Neurobiol Aging"},{"key":"3496_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0197-4580(96)00112-1","volume":"17","author":"J Ma","year":"1996","unstructured":"Ma J, Brewer HB Jr., Potter H. Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides. Neurobiol Aging. 1996;17:773\u201380.","journal-title":"Neurobiol Aging"},{"key":"3496_CR18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:1977\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3496_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/372092a0","volume":"372","author":"J Ma","year":"1994","unstructured":"Ma J, Yee A, Brewer HB Jr., Das S, Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 1994;372:92\u201394.","journal-title":"Nature"},{"key":"3496_CR20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1172\/JCI117407","volume":"94","author":"DA Sanan","year":"1994","unstructured":"Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer\u2019s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest. 1994;94:860\u20139.","journal-title":"J Clin Invest"},{"key":"3496_CR21","first-page":"1030","volume":"145","author":"T Wisniewski","year":"1994","unstructured":"Wisniewski T, Casta\u00f1o EM, Golabek A, Vogel T, Frangione B:. Acceleration of Alzheimer\u2019s fibril formation by apolipoprotein E in vitro. Am J Pathol. 1994;145:1030\u20135.","journal-title":"Am J Pathol"},{"key":"3496_CR22","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest. 2008;118:4002\u201313.","journal-title":"J Clin Invest"},{"key":"3496_CR23","doi-asserted-by":"publisher","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem. 1994;269:23403\u20136.","journal-title":"J Biol Chem"},{"key":"3496_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","volume":"43","author":"R Deane","year":"2004","unstructured":"Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, et al. LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron. 2004;43:333\u201344.","journal-title":"Neuron"},{"key":"3496_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3727\/194982412X13462021398010","volume":"14","author":"LN Nilsson","year":"2012","unstructured":"Nilsson LN, Gografe S, Costa DA, Hughes T, Dressler D, Potter H. Use of fused circulations to investigate the role of apolipoprotein E as amyloid catalyst and peripheral sink in alzheimer\u2019s disease. Technol Innov. 2012;14:199\u2013208.","journal-title":"Technol Innov"},{"key":"3496_CR26","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, Lopera F, O\u2019Hare M, Delgado-Tirado S, Marino C, Chmielewska N, et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25:1680\u20133.","journal-title":"Nat Med"},{"key":"3496_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1586\/14737159.2015.1002469","volume":"15","author":"C Reitz","year":"2015","unstructured":"Reitz C. Genetic diagnosis and prognosis of Alzheimer\u2019s disease: challenges and opportunities. Expert Rev Mol Diagn. 2015;15:339\u201348.","journal-title":"Expert Rev Mol Diagn"},{"key":"3496_CR28","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41591-019-0634-9","volume":"25","author":"KA Zalocusky","year":"2019","unstructured":"Zalocusky KA, Nelson MR, Huang Y. An Alzheimer\u2019s-disease-protective APOE mutation. Nat Med. 2019;25:1648\u20139.","journal-title":"Nat Med"},{"key":"3496_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.tins.2015.08.006","volume":"38","author":"SD Mhatre","year":"2015","unstructured":"Mhatre SD, Tsai CA, Rubin AJ, James ML, Andreasson KI. Microglial malfunction: the third rail in the development of Alzheimer\u2019s disease. Trends Neurosci. 2015;38:621\u201336.","journal-title":"Trends Neurosci"},{"key":"3496_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer\u2019s disease. Nat Rev Dis Primers. 2015;1:15056.","journal-title":"Nat Rev Dis Primers"},{"key":"3496_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, Luna G, Guzman E, Audouard M, Challis C, Sibih YE, et al. LRP1 is a master regulator of tau uptake and spread. Nature. 2020;580:381\u20135.","journal-title":"Nature"},{"key":"3496_CR32","first-page":"13452","volume":"273","author":"ZS Ji","year":"1998","unstructured":"Ji ZS, Pitas RE, Mahley RW. Differential cellular accumulation\/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4. J Biol Chem. 1998;273:13452\u201360.","journal-title":"Apolipoproteins E3 and E2 greater than e4. J Biol Chem"},{"key":"3496_CR33","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jamaneurol.2022.1166","volume":"79","author":"Y Le Guen","year":"2022","unstructured":"Le Guen Y, Belloy ME, Grenier-Boley B, de Rojas I, Castillo-Morales A, Jansen I, et al. Association of rare APOE missense variants V236E and R251G with risk of alzheimer disease. JAMA Neurol. 2022;79:652\u201363.","journal-title":"JAMA Neurol"},{"key":"3496_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261:921\u20133.","journal-title":"Science"},{"key":"3496_CR35","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/jama.279.10.751","volume":"279","author":"MX Tang","year":"1998","unstructured":"Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998;279:751\u20135.","journal-title":"JAMA"},{"key":"3496_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","volume":"72","author":"Y Huang","year":"2014","unstructured":"Huang Y, Mahley RW. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases. Neurobiol Dis. 2014;72:3\u201312.","journal-title":"Neurobiol Dis"},{"key":"3496_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J, Fu Y, Yamazaki Y, Ren Y, Davis MD, Liu CC, et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat Commun. 2020;11:5540.","journal-title":"Nat Commun"},{"key":"3496_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00401-024-02721-1","volume":"147","author":"P Bhattarai","year":"2024","unstructured":"Bhattarai P, Gunasekaran TI, Belloy ME, Reyes-Dumeyer D, J\u00fclich D, Tayran H, et al. Rare genetic variation in fibronectin 1 (FN1) protects against APOE\u03b54 in Alzheimer\u2019s disease. Acta Neuropathol. 2024;147:70.","journal-title":"Acta Neuropathol"},{"key":"3496_CR39","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.neuron.2024.01.008","volume":"112","author":"A Chemparathy","year":"2024","unstructured":"Chemparathy A, Le Guen Y, Chen S, Lee EG, Leong L, Gorzynski JE, et al. APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer\u2019s disease pathology. Neuron. 2024;112:1110\u2013e1115.","journal-title":"Neuron"},{"key":"3496_CR40","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J, et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron. 2018;98:1141\u2013e1147.","journal-title":"Neuron"},{"key":"3496_CR41","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamaneurol.2020.0414","volume":"77","author":"ME Belloy","year":"2020","unstructured":"Belloy ME, Napolioni V, Han SS, Le Guen Y, Greicius MD. Association of klotho-VS heterozygosity with risk of Alzheimer disease in individuals who carry APOE4. JAMA Neurol. 2020;77:849\u201362.","journal-title":"JAMA Neurol"},{"key":"3496_CR42","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1056\/NEJMoa2308583","volume":"390","author":"YT Quiroz","year":"2024","unstructured":"Quiroz YT, Aguillon D, Aguirre-Acevedo DC, Vasquez D, Zuluaga Y, Baena AY, et al. APOE3 christchurch heterozygosity and autosomal dominant Alzheimer\u2019s disease. N Engl J Med. 2024;390:2156\u201364.","journal-title":"N Engl J Med"},{"key":"3496_CR43","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","volume":"40","author":"RW Mahley","year":"1999","unstructured":"Mahley RW, Huang Y, Rall SC Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res. 1999;40:1933\u201349.","journal-title":"J Lipid Res"},{"key":"3496_CR44","doi-asserted-by":"crossref","unstructured":"Naguib S, Lopez-Lee C, Torres ER, Lee SI, Zhu J, Zhu D, et al. The R136S mutation in the APOE3 gene confers resilience against tau pathology via inhibition of the cGAS-STING-IFN pathway. Immunity 2025;58:1931\u201347.e1939.","DOI":"10.1016\/j.immuni.2025.05.023"},{"key":"3496_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1172\/JCI113096","volume":"80","author":"MR Wardell","year":"1987","unstructured":"Wardell MR, Brennan SO, Janus ED, Fraser R, Carrell RW. Apolipoprotein E2-Christchurch (136 Arg-Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J Clin Invest. 1987;80:483\u201390.","journal-title":"J Clin Invest"},{"key":"3496_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"3496_CR47","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1016\/j.ymthe.2024.11.003","volume":"32","author":"C G\u00fcnaydin","year":"2024","unstructured":"G\u00fcnaydin C, Sondhi D, Kaminsky SM, Lephart HC, Leopold PL, Hackett NR, et al. AAVrh.10 delivery of novel APOE2-christchurch variant suppresses amyloid and Tau pathology in Alzheimer\u2019s disease mice. Mol Ther. 2024;32:4303\u201318.","journal-title":"Mol Ther"},{"key":"3496_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24904-z","volume":"8","author":"JN Rauch","year":"2018","unstructured":"Rauch JN, Chen JJ, Sorum AW, Miller GM, Sharf T, See SK, et al. Tau internalization is regulated by 6-O sulfation on heparan sulfate proteoglycans (HSPGs). Sci Rep. 2018;8:6382.","journal-title":"Sci Rep"},{"key":"3496_CR49","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Song S, Parhizkar S, Lord J, Zhu Y, Strickland MR, et al. APOE3ch alters microglial response and suppresses A\u03b2-induced tau seeding and spread. Cell. 2024;187:428\u2013e420.","journal-title":"Cell"},{"key":"3496_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70589","volume":"21","author":"X Tian","year":"2025","unstructured":"Tian X, Rivera EK, Hwang I, Nikitina AA, Smith JA, Cho YJ, et al. Protective mechanisms against Alzheimer\u2019s disease in APOE3-Christchurch homozygous astrocytes. Alzheimers Dement. 2025;21:e70589.","journal-title":"Alzheimers Dement"},{"key":"3496_CR51","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3233\/JAD-151101","volume":"51","author":"S Simonovitch","year":"2016","unstructured":"Simonovitch S, Schmukler E, Bespalko A, Iram T, Frenkel D, Holtzman DM, et al. Impaired Autophagy in APOE4 Astrocytes. J Alzheimers Dis. 2016;51:915\u201327.","journal-title":"J Alzheimers Dis"},{"key":"3496_CR52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000;157:277\u201386.","journal-title":"Am J Pathol"},{"key":"3496_CR53","doi-asserted-by":"publisher","first-page":"21821","DOI":"10.1074\/jbc.M112109200","volume":"277","author":"ZS Ji","year":"2002","unstructured":"Ji ZS, Miranda RD, Newhouse YM, Weisgraber KH, Huang Y, Mahley RW. Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. J Biol Chem. 2002;277:21821\u20138.","journal-title":"J Biol Chem"},{"key":"3496_CR54","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.neuron.2021.05.034","volume":"109","author":"Y Shi","year":"2021","unstructured":"Shi Y, Andhey PS, Ising C, Wang K, Snipes LL, Boyer K, et al. Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. Neuron. 2021;109:2413\u2013e2417.","journal-title":"Neuron"},{"key":"3496_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-024-00793-x","volume":"20","author":"KM Tran","year":"2025","unstructured":"Tran KM, Kwang NE, Butler CA, Gomez-Arboledas A, Kawauchi S, Mar C, et al. APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology. Mol Neurodegener. 2025;20:9.","journal-title":"Mol Neurodegener"},{"key":"3496_CR56","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1074\/jbc.M411719200","volume":"280","author":"M Futamura","year":"2005","unstructured":"Futamura M, Dhanasekaran P, Handa T, Phillips MC, Lund-Katz S, Saito H. Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces. J Biol Chem. 2005;280:5414\u201322.","journal-title":"J Biol Chem"},{"key":"3496_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1399965","volume":"17","author":"HJ Moon","year":"2024","unstructured":"Moon HJ, Luo Y, Chugh D, Zhao L. Human apolipoprotein E glycosylation and sialylation: from structure to function. Front Mol Neurosci. 2024;17:1399965.","journal-title":"Front Mol Neurosci"},{"key":"3496_CR58","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1073\/pnas.1106420108","volume":"108","author":"J Chen","year":"2011","unstructured":"Chen J, Li Q, Wang J. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci USA. 2011;108:14813\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3496_CR59","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1016\/S0021-9258(18)68957-4","volume":"263","author":"A Lalazar","year":"1988","unstructured":"Lalazar A, Weisgraber KH, Rall SC Jr., Giladi H, Innerarity TL, Levanon AZ, et al. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J Biol Chem. 1988;263:3542\u20135.","journal-title":"J Biol Chem"},{"key":"3496_CR60","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296\u2013w303.","journal-title":"Nucleic Acids Res"},{"key":"3496_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1373568","volume":"17","author":"P Perez-Corredor","year":"2024","unstructured":"Perez-Corredor P, Vanderleest TE, Vacano GN, Sanchez JS, Villalba-Moreno ND, Marino C, et al. APOE3 Christchurch modulates \u03b2-catenin\/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer\u2019s cases. Front Mol Neurosci. 2024;17:1373568.","journal-title":"Front Mol Neurosci"},{"key":"3496_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13097","volume":"32","author":"JL Littau","year":"2022","unstructured":"Littau JL, Velilla L, Hase Y, Villalba-Moreno ND, Hagel C, Drexler D, et al. Evidence of beta amyloid independent small vessel disease in familial Alzheimer\u2019s disease. Brain Pathol. 2022;32:e13097.","journal-title":"Brain Pathol"},{"key":"3496_CR63","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn.2017.48","volume":"18","author":"K Kisler","year":"2017","unstructured":"Kisler K, Nelson AR, Montagne A, Zlokovic BV. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017;18:419\u201334.","journal-title":"Nat Rev Neurosci"},{"key":"3496_CR64","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0896-6273(00)80194-4","volume":"17","author":"W Liedtke","year":"1996","unstructured":"Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, et al. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron. 1996;17:607\u201315.","journal-title":"Neuron"},{"key":"3496_CR65","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","volume":"163","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and dysfunction of the blood-brain barrier. Cell. 2015;163:1064\u201378.","journal-title":"Cell"},{"key":"3496_CR66","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19:1584\u201396.","journal-title":"Nat Med"},{"key":"3496_CR67","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12:723\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"3496_CR68","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350.","journal-title":"Nat Rev Neurol"},{"key":"3496_CR69","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/micc.12111","volume":"21","author":"JM Dave","year":"2014","unstructured":"Dave JM, Bayless KJ. Vimentin as an integral regulator of cell adhesion and endothelial sprouting. Microcirculation. 2014;21:333\u201344.","journal-title":"Microcirculation"},{"key":"3496_CR70","doi-asserted-by":"publisher","first-page":"29414","DOI":"10.1074\/jbc.M704152200","volume":"282","author":"SM Sullivan","year":"2007","unstructured":"Sullivan SM, Lee A, Bj\u00f6rkman ST, Miller SM, Sullivan RK, Poronnik P, et al. Cytoskeletal anchoring of GLAST determines susceptibility to brain damage: an identified role for GFAP. J Biol Chem. 2007;282:29414\u201323.","journal-title":"J Biol Chem"},{"key":"3496_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1\u2013105.","journal-title":"Prog Neurobiol"},{"key":"3496_CR72","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.neuroscience.2014.07.019","volume":"277","author":"RC Roberts","year":"2014","unstructured":"Roberts RC, Roche JK, McCullumsmith RE. Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study. Neuroscience. 2014;277:522\u201340.","journal-title":"Neuroscience"},{"key":"3496_CR73","doi-asserted-by":"publisher","first-page":"10404","DOI":"10.1523\/JNEUROSCI.2066-16.2016","volume":"36","author":"M Armbruster","year":"2016","unstructured":"Armbruster M, Hanson E, Dulla CG. Glutamate clearance is locally modulated by presynaptic neuronal activity in the cerebral cortex. J Neurosci. 2016;36:10404\u201315.","journal-title":"J Neurosci"},{"key":"3496_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13119","volume":"33","author":"J Henao-Restrepo","year":"2023","unstructured":"Henao-Restrepo J, L\u00f3pez-Murillo C, Valderrama-Carmona P, Orozco-Santa N, Gomez J, Guti\u00e9rrez-Vargas J, et al. Gliovascular alterations in sporadic and familial Alzheimer\u2019s disease: APOE3 Christchurch homozygote glioprotection. Brain Pathol. 2023;33:e13119.","journal-title":"Brain Pathol"},{"key":"3496_CR75","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO, et al. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide. J Neurosci. 2012;32:15181\u201392.","journal-title":"J Neurosci"},{"key":"3496_CR76","unstructured":"Fersht A: Structure and mechanism in protein science: a guide to enzyme catalysis and protein folding: Macmillan; 1999."},{"key":"3496_CR77","doi-asserted-by":"publisher","first-page":"10571","DOI":"10.1021\/bi9626362","volume":"36","author":"S Aleshkov","year":"1997","unstructured":"Aleshkov S, Abraham CR, Zannis VI. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer\u2019s disease. Biochemistry. 1997;36:10571\u201380.","journal-title":"Biochemistry"},{"key":"3496_CR78","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/bj3480359","volume":"348","author":"T Tokuda","year":"2000","unstructured":"Tokuda T, Calero M, Matsubara E, Vidal R, Kumar A, Permanne B, et al. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer\u2019s amyloid beta peptides. Biochem J. 2000;348:359\u201365.","journal-title":"Biochem J"},{"key":"3496_CR79","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/imr.13414","volume":"327","author":"PB Lin","year":"2024","unstructured":"Lin PB, Holtzman DM. Current insights into apolipoprotein E and the immune response in Alzheimer\u2019s disease. Immunol Rev. 2024;327:43\u201352.","journal-title":"Immunol Rev"},{"key":"3496_CR80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1326-9-11","volume":"9","author":"CW Medway","year":"2014","unstructured":"Medway CW, Abdul-Hay S, Mims T, Ma L, Bisceglio G, Zou F, et al. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer\u2019s disease. Mol Neurodegener. 2014;9:11.","journal-title":"Mol Neurodegener"},{"key":"3496_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc9375","volume":"13","author":"CC Liu","year":"2021","unstructured":"Liu CC, Murray ME, Li X, Zhao N, Wang N, Heckman MG, et al. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci Transl Med. 2021;13:eabc9375.","journal-title":"Sci Transl Med"},{"key":"3496_CR82","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","volume":"31","author":"DM Hatters","year":"2006","unstructured":"Hatters DM, Peters-Libeu CA, Weisgraber KH. Apolipoprotein E structure: insights into function. Trends Biochem Sci. 2006;31:445\u201354.","journal-title":"Trends Biochem Sci"},{"key":"3496_CR83","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-90-481-8622-8_7","volume":"51","author":"S Lund-Katz","year":"2010","unstructured":"Lund-Katz S, Phillips MC. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell Biochem. 2010;51:183\u2013227.","journal-title":"Subcell Biochem"},{"key":"3496_CR84","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jmb.2003.09.059","volume":"334","author":"N Choy","year":"2003","unstructured":"Choy N, Raussens V, Narayanaswami V. Inter-molecular coiled-coil formation in human apolipoprotein E C-terminal domain. J Mol Biol. 2003;334:527\u201339.","journal-title":"J Mol Biol"},{"key":"3496_CR85","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G. Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009;10:333\u201344.","journal-title":"Nat Rev Neurosci"},{"key":"3496_CR86","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet. 1997;17:263\u20134.","journal-title":"Nat Genet"},{"key":"3496_CR87","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystr\u00f6m S, Nilsson KP, Song WM, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047\u201358.","journal-title":"J Exp Med"},{"key":"3496_CR88","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13024-022-00556-6","volume":"17","author":"G Bu","year":"2022","unstructured":"Bu G. APOE targeting strategy in Alzheimer\u2019s disease: lessons learned from protective variants. Mol Neurodegener. 2022;17:51.","journal-title":"Mol Neurodegener"},{"key":"3496_CR89","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/JMN:23:3:189","volume":"23","author":"Y Huang","year":"2004","unstructured":"Huang Y, Weisgraber KH, Mucke L, Mahley RW. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer\u2019s disease. J Mol Neurosci. 2004;23:189\u2013204.","journal-title":"J Mol Neurosci"},{"key":"3496_CR90","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/B978-0-12-800149-3.00005-6","volume":"87","author":"V Chouraki","year":"2014","unstructured":"Chouraki V, Seshadri S. Genetics of Alzheimer\u2019s disease. Adv Genet. 2014;87:245\u201394.","journal-title":"Adv Genet"},{"key":"3496_CR91","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"E Genin","year":"2011","unstructured":"Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry. 2011;16:903\u20137.","journal-title":"Mol Psychiatry"},{"key":"3496_CR92","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA. 1997;278:1349\u201356. APOE and Alzheimer Disease Meta Analysis Consortium","journal-title":"JAMA"},{"key":"3496_CR93","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/cells14151216","volume":"14","author":"J Narasimhappagari","year":"2025","unstructured":"Narasimhappagari J, Liu L, Balasubramaniam M, Ayyadevara S, Griffin WST. When two worlds collide: the contribution and association between genetics (APOE\u03b54) and neuroinflammation (IL-1\u03b2) in Alzheimer\u2019s Neuropathogenesis. Cells. 2025;14:1216.","journal-title":"Cells"},{"key":"3496_CR94","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s42003-024-05767-9","volume":"7","author":"M Balasubramaniam","year":"2024","unstructured":"Balasubramaniam M, Narasimhappagari J, Liu L, Ganne A, Ayyadevara S, Atluri R, et al. Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer\u2019s disease by targeted small molecules. Commun Biol. 2024;7:60.","journal-title":"Commun Biol"},{"key":"3496_CR95","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrd.2017.155","volume":"16","author":"C Li","year":"2017","unstructured":"Li C, G\u00f6tz J. Tau-based therapies in neurodegeneration: opportunities and challenges. Nat Rev Drug Discov. 2017;16:863\u201383.","journal-title":"Nat Rev Drug Discov"},{"key":"3496_CR96","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1073\/pnas.0812697106","volume":"106","author":"F Agosta","year":"2009","unstructured":"Agosta F, Vossel KA, Miller BL, Migliaccio R, Bonasera SJ, Filippi M, et al. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer\u2019s disease and frontotemporal dementia. Proc Natl Acad Sci USA. 2009;106:2018\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3496_CR97","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549:523\u20137.","journal-title":"Nature"},{"key":"3496_CR98","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","volume":"77","author":"J Therriault","year":"2020","unstructured":"Therriault J, Benedet AL, Pascoal TA, Mathotaarachchi S, Chamoun M, Savard M, et al. Association of apolipoprotein E \u03b54 with medial temporal tau independent of amyloid-\u03b2. JAMA Neurol. 2020;77:470\u20139.","journal-title":"JAMA Neurol"},{"key":"3496_CR99","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.neuron.2017.09.053","volume":"96","author":"I Farhy-Tselnicker","year":"2017","unstructured":"Farhy-Tselnicker I, van Casteren ACM, Lee A, Chang VT, Aricescu AR, Allen NJ. Astrocyte-secreted glypican 4 regulates release of neuronal pentraxin 1 from axons to induce functional synapse formation. Neuron. 2017;96:428\u2013e413.","journal-title":"Neuron"},{"key":"3496_CR100","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature11059","volume":"486","author":"NJ Allen","year":"2012","unstructured":"Allen NJ, Bennett ML, Foo LC, Wang GX, Chakraborty C, Smith SJ, et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature. 2012;486:410\u20134.","journal-title":"Nature"},{"key":"3496_CR101","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10:698\u2013712.","journal-title":"Nat Rev Drug Discov"},{"key":"3496_CR102","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1038\/s41591-025-03835-z","volume":"31","author":"A Shvetcov","year":"2025","unstructured":"Shvetcov A, Johnson ECB, Winchester LM, Walker KA, Wilkins HM, Thompson TG, et al. APOE \u03b54 carriers share immune-related proteomic changes across neurodegenerative diseases. Nat Med. 2025;31:2590\u2013601.","journal-title":"Nat Med"},{"key":"3496_CR103","doi-asserted-by":"publisher","first-page":"42504","DOI":"10.18632\/oncotarget.6391","volume":"6","author":"Z Shang","year":"2015","unstructured":"Shang Z, Lv H, Zhang M, Duan L, Wang S, Li J, et al. Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer\u2019s disease in Caribbean Hispanic individuals. Oncotarget. 2015;6:42504\u201314.","journal-title":"Oncotarget"},{"key":"3496_CR104","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5","volume":"14","author":"BJ Gurland","year":"1999","unstructured":"Gurland BJ, Wilder DE, Lantigua R, Stern Y, Chen J, Killeffer EH, et al. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry. 1999;14:481\u201393.","journal-title":"Int J Geriatr Psychiatry"},{"key":"3496_CR105","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nature09788","volume":"472","author":"MA Burguillos","year":"2011","unstructured":"Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, et al. Caspase signalling controls microglia activation and neurotoxicity. Nature. 2011;472:319\u201324.","journal-title":"Nature"},{"key":"3496_CR106","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217:459\u201372.","journal-title":"J Cell Biol"},{"key":"3496_CR107","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1212\/01.wnl.0000284596.95156.48","volume":"70","author":"CA Szekely","year":"2008","unstructured":"Szekely CA, Breitner JC, Fitzpatrick AL, Rea TD, Psaty BM, Kuller LH, et al. NSAID use and dementia risk in the cardiovascular health study: role of APOE and NSAID type. Neurology. 2008;70:17\u201324.","journal-title":"Neurology"},{"key":"3496_CR108","doi-asserted-by":"publisher","first-page":"eabe9716","DOI":"10.1126\/sciadv.abe9716","volume":"7","author":"S Schumacher","year":"2021","unstructured":"Schumacher S, Dedden D, Nunez RV, Matoba K, Takagi J, Biert\u00fcmpfel C, et al. Structural insights into integrin \u03b1(5)\u03b2(1) opening by fibronectin ligand. Sci Adv. 2021;7:eabe9716.","journal-title":"Sci Adv"},{"key":"3496_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.575598","volume":"11","author":"D Michalski","year":"2020","unstructured":"Michalski D, Spielvogel E, Puchta J, Reimann W, Barthel H, Nitzsche B, et al. Increased immunosignals of collagen IV and fibronectin indicate ischemic consequences for the neurovascular matrix adhesion zone in various animal models and human stroke tissue. Front Physiol. 2020;11:575598.","journal-title":"Front Physiol"},{"key":"3496_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13606","volume":"21","author":"T Patel","year":"2022","unstructured":"Patel T, Carnwath TP, Wang X, Allen M, Lincoln SJ, Lewis-Tuffin LJ, et al. Transcriptional landscape of human microglia implicates age, sex, and APOE-related immunometabolic pathway perturbations. Aging Cell. 2022;21:e13606.","journal-title":"Aging Cell"},{"key":"3496_CR111","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrn1326","volume":"5","author":"J Silver","year":"2004","unstructured":"Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci. 2004;5:146\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"3496_CR112","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32:6391\u2013410.","journal-title":"J Neurosci"},{"key":"3496_CR113","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","volume":"29","author":"B Bellaver","year":"2023","unstructured":"Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ, et al. Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease. Nat Med. 2023;29:1775\u201381.","journal-title":"Nat Med"},{"key":"3496_CR114","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00401-022-02431-6","volume":"144","author":"AJ Lee","year":"2022","unstructured":"Lee AJ, Raghavan NS, Bhattarai P, Siddiqui T, Sariya S, Reyes-Dumeyer D, et al. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer\u2019s disease. Acta Neuropathol. 2022;144:59\u201379.","journal-title":"Acta Neuropathol"},{"key":"3496_CR115","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14:388\u2013405.","journal-title":"Lancet Neurol"},{"key":"3496_CR116","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0896-6273(00)80187-7","volume":"17","author":"DM Paresce","year":"1996","unstructured":"Paresce DM, Ghosh RN, Maxfield FR. Microglial cells internalize aggregates of the Alzheimer\u2019s disease amyloid beta-protein via a scavenger receptor. Neuron. 1996;17:553\u201365.","journal-title":"Neuron"},{"key":"3496_CR117","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1112766","volume":"309","author":"H Kurosu","year":"2005","unstructured":"Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005;309:1829\u201333.","journal-title":"Science"},{"key":"3496_CR118","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1073\/pnas.022484299","volume":"99","author":"DE Arking","year":"2002","unstructured":"Arking DE, Krebsova A, Macek M Sr., Macek M Jr., Arking A, Mian IS, et al. Association of human aging with a functional variant of klotho. Proc Natl Acad Sci USA. 2002;99:856\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3496_CR119","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/gerona\/gly261","volume":"74","author":"M Ullah","year":"2019","unstructured":"Ullah M, Sun Z. Klotho deficiency accelerates stem cells aging by impairing telomerase activity. J Gerontol A Biol Sci Med Sci. 2019;74:1396\u2013407.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3496_CR120","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol. 2006;59:512\u20139.","journal-title":"Ann Neurol"},{"key":"3496_CR121","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol. 2010;67:122\u201331.","journal-title":"Ann Neurol"},{"key":"3496_CR122","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr.","year":"2013","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207\u201316.","journal-title":"Lancet Neurol"},{"key":"3496_CR123","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1474-4422(16)30125-9","volume":"15","author":"SC Burnham","year":"2016","unstructured":"Burnham SC, Bourgeat P, Dor\u00e9 V, Savage G, Brown B, Laws S, et al. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer\u2019s disease pathophysiology (SNAP) or Alzheimer\u2019s disease pathology: a longitudinal study. Lancet Neurol. 2016;15:1044\u201353.","journal-title":"Lancet Neurol"},{"key":"3496_CR124","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","volume":"12","author":"SJ Vos","year":"2013","unstructured":"Vos SJ, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, et al. Preclinical Alzheimer\u2019s disease and its outcome: a longitudinal cohort study. Lancet Neurol. 2013;12:957\u201365.","journal-title":"Lancet Neurol"},{"key":"3496_CR125","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1001\/jama.2015.4669","volume":"313","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015;313:1939\u201349.","journal-title":"JAMA"},{"key":"3496_CR126","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jamaneurol.2017.4325","volume":"75","author":"YY Lim","year":"2018","unstructured":"Lim YY, Kalinowski P, Pietrzak RH, Laws SM, Burnham SC, Ames D, et al. Association of \u03b2-amyloid and apolipoprotein E \u03b54 with memory decline in preclinical alzheimer disease. JAMA Neurol. 2018;75:488\u201394.","journal-title":"JAMA Neurol"},{"key":"3496_CR127","doi-asserted-by":"publisher","first-page":"17362","DOI":"10.1073\/pnas.1012568107","volume":"107","author":"H Li","year":"2010","unstructured":"Li H, Wang B, Wang Z, Guo Q, Tabuchi K, Hammer RE, et al. Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP. Proc Natl Acad Sci USA. 2010;107:17362\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3496_CR128","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci. 2011;34:185\u2013204.","journal-title":"Annu Rev Neurosci"},{"key":"3496_CR129","doi-asserted-by":"publisher","first-page":"19796","DOI":"10.1073\/pnas.0709805104","volume":"104","author":"CD Chen","year":"2007","unstructured":"Chen CD, Podvin S, Gillespie E, Leeman SE, Abraham CR. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci USA. 2007;104:19796\u2013801.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3496_CR130","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1016\/j.febslet.2009.09.009","volume":"583","author":"L Bloch","year":"2009","unstructured":"Bloch L, Sineshchekova O, Reichenbach D, Reiss K, Saftig P, Kuro-o M, et al. Klotho is a substrate for alpha-, beta- and gamma-secretase. FEBS Lett. 2009;583:3221\u20134.","journal-title":"FEBS Lett"},{"key":"3496_CR131","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3389\/fcell.2020.00734","volume":"8","author":"NC Inestrosa","year":"2020","unstructured":"Inestrosa NC, Tapia-Rojas C, Lindsay CB, Zolezzi JM. Wnt signaling pathway dysregulation in the aging brain: lessons from the octodon degus. Front Cell Dev Biol. 2020;8:734.","journal-title":"Front Cell Dev Biol"},{"key":"3496_CR132","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0002-9440(10)63355-X","volume":"165","author":"M Sadowski","year":"2004","unstructured":"Sadowski M, Pankiewicz J, Scholtzova H, Ripellino JA, Li Y, Schmidt SD, et al. A synthetic peptide blocking the apolipoprotein E\/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice. Am J Pathol. 2004;165:937\u201348.","journal-title":"Am J Pathol"},{"key":"3496_CR133","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13195-022-01020-9","volume":"14","author":"NR Johnson","year":"2022","unstructured":"Johnson NR, Wang AC, Coughlan C, Sillau S, Lucero E, Viltz L, et al. Imipramine and olanzapine block apoE4-catalyzed polymerization of A\u03b2 and show evidence of improving Alzheimer\u2019s disease cognition. Alzheimers Res Ther. 2022;14:88.","journal-title":"Alzheimers Res Ther"},{"key":"3496_CR134","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C, Najm R, Xu Q, Jeong DE, Walker D, Balestra ME, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med. 2018;24:647\u201357.","journal-title":"Nat Med"},{"key":"3496_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2024.11.002","volume":"20","author":"AK Rottner","year":"2025","unstructured":"Rottner AK, Lundin A, Li S, Firth M, Maresca M, Sienski G. Optimized prime editing of the Alzheimer\u2019s disease-associated APOE4 mutation. Stem Cell Reports. 2025;20:102372.","journal-title":"Stem Cell Reports"},{"key":"3496_CR136","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.3390\/ijms21176240","volume":"21","author":"A Kantor","year":"2020","unstructured":"Kantor A, McClements ME, MacLaren RE. CRISPR-Cas9 DNA Base-Editing and Prime-Editing. Int J Mol Sci. 2020;21:6240.","journal-title":"Int J Mol Sci"},{"key":"3496_CR137","first-page":"568","volume":"13","author":"SH MacKenzie","year":"2010","unstructured":"MacKenzie SH, Schipper JL, Clark AC. The potential for caspases in drug discovery. Curr Opin Drug Discov Devel. 2010;13:568\u201376.","journal-title":"Curr Opin Drug Discov Devel"},{"key":"3496_CR138","doi-asserted-by":"crossref","unstructured":"Golden LR, Siano DS, Stephens IO, MacLean SM, Saito K, Nolt GL, et al. APOE4 to APOE2 allelic switching in mice improves Alzheimer\u2019s disease-related metabolic signatures, neuropathology and cognition. Nat Neurosci. 2025.","DOI":"10.1038\/s41593-025-02094-y"},{"key":"3496_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20210081","volume":"2","author":"Z Xu","year":"2022","unstructured":"Xu Z, Wang Q, Zhong H, Jiang Y, Shi X, Yuan B, et al. Carrier strategies boost the application of CRISPR\/Cas system in gene therapy. Exploration (Beijing). 2022;2:20210081.","journal-title":"Exploration (Beijing)"},{"key":"3496_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/INMD.20220014","volume":"1","author":"W Tang","year":"2023","unstructured":"Tang W, Liu J, Ding B. Nucleic acid nanostructure for delivery of CRISPR\/Cas9\u2010based gene editing system. Interdisciplinary Medicine. 2023;1:e20220014.","journal-title":"Interdisciplinary Medicine"},{"key":"3496_CR141","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld J, Yip O, Kim MJ, Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci. 2024;25:91\u2013110.","journal-title":"Nat Rev Neurosci"},{"key":"3496_CR142","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/d41586-024-00275-6","volume":"626","author":"M Lenharo","year":"2024","unstructured":"Lenharo M. Move over, CRISPR: RNA-editing therapies pick up steam. Nature. 2024;626:933\u20134.","journal-title":"Nature"},{"key":"3496_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/srep31450","volume":"6","author":"R Balez","year":"2016","unstructured":"Balez R, Steiner N, Engel M, Mu\u00f1oz SS, Lum JS, Wu Y, et al. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer\u2019s disease. Sci Rep. 2016;6:31450.","journal-title":"Sci Rep"},{"key":"3496_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1262-5","volume":"16","author":"AM Hossini","year":"2015","unstructured":"Hossini AM, Megges M, Prigione A, Lichtner B, Toliat MR, Wruck W, et al. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer\u2019s disease donor as a model for investigating AD-associated gene regulatory networks. BMC Genomics. 2015;16:84.","journal-title":"BMC Genomics"},{"key":"3496_CR145","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/hmg\/ddu064","volume":"23","author":"CR Muratore","year":"2014","unstructured":"Muratore CR, Rice HC, Srikanth P, Callahan DG, Shin T, Benjamin LN, et al. The familial Alzheimer\u2019s disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. Hum Mol Genet. 2014;23:3523\u201336.","journal-title":"Hum Mol Genet"},{"key":"3496_CR146","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.addr.2007.08.035","volume":"60","author":"MI Phillips","year":"2008","unstructured":"Phillips MI, Tang YL. Genetic modification of stem cells for transplantation. Adv Drug Deliv Rev. 2008;60:160\u201372.","journal-title":"Adv Drug Deliv Rev"},{"key":"3496_CR147","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51:2778\u201386.","journal-title":"J Chem Inf Model"},{"key":"3496_CR148","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan Y, Tao H, He J, Huang SY. The HDOCK server for integrated protein-protein docking. Nat Protoc. 2020;15:1829\u201352.","journal-title":"Nat Protoc"},{"key":"3496_CR149","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","volume":"53","author":"UniProt Consortium","year":"2025","unstructured":"UniProt Consortium. UniProt: the universal protein knowledgebase in 2025. Nucleic Acids Res. 2025;53:D609\u2013d617.","journal-title":"Nucleic Acids Res"},{"key":"3496_CR150","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41587-021-01156-3","volume":"40","author":"F Teufel","year":"2022","unstructured":"Teufel F, Almagro Armenteros JJ, Johansen AR, G\u00edslason MH, Pihl SI, Tsirigos KD, et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat Biotechnol. 2022;40:1023\u20135.","journal-title":"Nat Biotechnol"},{"key":"3496_CR151","doi-asserted-by":"crossref","unstructured":"B. Rupp BWS, M. Forstner: Apolipoprotein E3 (APOE3) truncation mutant 165. In.; 1999.","DOI":"10.2210\/pdb1or2\/pdb"},{"key":"3496_CR152","doi-asserted-by":"crossref","unstructured":"Verderame JR, Kantardjieff K., Segelke B, Weisgraber K, Rupp B Apolipoprotein E4, 22k domain. In. 2002.","DOI":"10.2210\/pdb1gs9\/pdb"},{"key":"3496_CR153","doi-asserted-by":"crossref","unstructured":"Jeon H, Meng W, Takagi J, Eck MJ, Springer TA, Blacklow SC Crystal Structure of the LDL Receptor YWTD-EGF Domain Pair In. 2001.","DOI":"10.2210\/pdb1ijq\/pdb"},{"key":"3496_CR154","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res. 2000;28:235\u201342.","journal-title":"Nucleic Acids Res"},{"key":"3496_CR155","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nm1096-1146","volume":"2","author":"CA Lemere","year":"1996","unstructured":"Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, et al. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med. 1996;2:1146\u201350.","journal-title":"Nat Med"},{"key":"3496_CR156","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00401-020-02249-0","volume":"141","author":"D Sepulveda-Falla","year":"2021","unstructured":"Sepulveda-Falla D, Chavez-Gutierrez L, Portelius E, V\u00e9lez JI, Dujardin S, Barrera-Ocampo A, et al. A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer\u2019s disease. Acta Neuropathol. 2021;141:217\u201333.","journal-title":"Acta Neuropathol"},{"key":"3496_CR157","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abe3947","volume":"13","author":"FA Sayed","year":"2021","unstructured":"Sayed FA, Kodama L, Fan L, Carling GK, Udeochu JC, Le D, et al. AD-linked R47H-TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation. Sci Transl Med. 2021;13:eabe3947.","journal-title":"Sci Transl Med"},{"key":"3496_CR158","doi-asserted-by":"publisher","first-page":"44795","DOI":"10.1074\/jbc.M408127200","volume":"279","author":"FM Harris","year":"2004","unstructured":"Harris FM, Brecht WJ, Xu Q, Mahley RW, Huang Y. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem. 2004;279:44795\u2013801.","journal-title":"J Biol Chem"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03496-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03496-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03496-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:03:22Z","timestamp":1781510602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03496-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":158,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3496"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03496-5","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}